In addition, negatively charged nanoparticles were more likely to preferentially target the IBD site due to the accumulation of positively charged proteins such as eosinophilic cationic proteins, transferrin, and antimicrobial peptides, which provided the advantage of the negatively charged CUR/EMO NE@SA targeting to colitis. The gene discussed is TF; the disease is inflammatory bowel disease.